1. How can psychotropic medications help children and youth? (1 min 34 sec)
2. How can prescribers communicate with children, youth, and caregivers about psychotropic medication efficacy and side effects? (2 min 33 sec)
3. How can a prescriber benefit from using the PMMC with their patients? (1 min 5 sec)
4. Where can prescribers find valid and reliable evidence about psychotropic medications? (1 min 2 sec)
5. What about tracking the benefits of medication? (1 min 48 sec)
6. Discussing MedWise (the new incoming electronic PMMC (2 min 50 sec)
Help us evaluate our educational materials by filling out a brief survey
Ninan, A., Stewart, S. L., Theall, L., King, G., Evans, R., Baiden, P., & Brown, A. (2014). Psychotropic medication monitoring checklists: Use and utility for children in residential care. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 23(1), 38. (Article available from NIH)
Ninan, A., Stewart, S. L., Theall, L. A., Katuwapitiya, S., & Kam, C. (2014). Adverse Effects of Psychotropic Medications in Children: Predictive Factors.Journal of the Canadian Academy of Child and Adolescent Psychiatry, 23(3), 218. (Article available from NIH)